Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Abstract Background The toxic effect of doxorubicin on the heart limits its clinical usage in cancer therapy. This work intended to investigate, for the first time, the efficacy of rifampicin administration against doxorubicin-induction of cardiotoxicity in mice. Forty adult male albino mice were di...
Main Authors: | Omnia A. Basal, Rasha F. Zahran, Entsar A. Saad |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-08-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43044-023-00403-z |
Similar Items
-
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
by: Ziad Hijazi, et al.
Published: (2017-11-01) -
Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity
by: Hayder M. Al-kuraishy, et al.
Published: (2022-10-01) -
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
by: Umberto Attanasio, et al.
Published: (2024-02-01) -
Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries
by: Martin E. Blohm, et al.
Published: (2019-07-01) -
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
by: Lars Michel, et al.
Published: (2020-04-01)